| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rotavirus | 52 | 2023 | 366 | 5.070 |
Why?
|
| Norovirus | 24 | 2026 | 288 | 3.280 |
Why?
|
| Rotavirus Infections | 34 | 2023 | 281 | 3.160 |
Why?
|
| Virus Replication | 30 | 2026 | 599 | 3.000 |
Why?
|
| Viral Nonstructural Proteins | 20 | 2020 | 140 | 2.310 |
Why?
|
| Organoids | 13 | 2026 | 307 | 1.940 |
Why?
|
| Host-Pathogen Interactions | 9 | 2026 | 260 | 1.860 |
Why?
|
| Caliciviridae Infections | 17 | 2026 | 289 | 1.600 |
Why?
|
| Toxins, Biological | 10 | 2019 | 40 | 1.550 |
Why?
|
| Gastroenteritis | 15 | 2025 | 307 | 1.530 |
Why?
|
| Capsid Proteins | 15 | 2025 | 150 | 1.500 |
Why?
|
| Virion | 12 | 2020 | 116 | 1.060 |
Why?
|
| Cell Culture Techniques | 4 | 2021 | 275 | 0.960 |
Why?
|
| Virus Assembly | 8 | 2025 | 37 | 0.880 |
Why?
|
| Viruses | 3 | 2022 | 118 | 0.840 |
Why?
|
| Glycoproteins | 10 | 2013 | 348 | 0.830 |
Why?
|
| Intestines | 10 | 2026 | 592 | 0.830 |
Why?
|
| Gastrointestinal Diseases | 3 | 2021 | 340 | 0.770 |
Why?
|
| Norwalk virus | 11 | 2013 | 115 | 0.730 |
Why?
|
| Capsid | 13 | 2025 | 96 | 0.720 |
Why?
|
| Epithelial Cells | 6 | 2022 | 900 | 0.670 |
Why?
|
| Antibodies, Viral | 14 | 2014 | 1175 | 0.650 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 251 | 0.650 |
Why?
|
| Intestinal Mucosa | 8 | 2024 | 765 | 0.630 |
Why?
|
| COP-Coated Vesicles | 1 | 2019 | 4 | 0.630 |
Why?
|
| Lipid Droplets | 2 | 2020 | 51 | 0.630 |
Why?
|
| Virus Internalization | 4 | 2025 | 59 | 0.620 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 225 | 0.620 |
Why?
|
| Autophagy | 3 | 2019 | 424 | 0.500 |
Why?
|
| Stem Cells | 6 | 2021 | 714 | 0.480 |
Why?
|
| RNA, Viral | 11 | 2024 | 512 | 0.470 |
Why?
|
| Bile Acids and Salts | 3 | 2024 | 259 | 0.460 |
Why?
|
| Intestine, Small | 4 | 2021 | 287 | 0.450 |
Why?
|
| Calcium | 6 | 2023 | 1039 | 0.450 |
Why?
|
| Epitope Mapping | 1 | 2014 | 68 | 0.440 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2014 | 32 | 0.430 |
Why?
|
| Endoplasmic Reticulum | 5 | 2019 | 209 | 0.420 |
Why?
|
| Cell Line | 16 | 2020 | 2591 | 0.410 |
Why?
|
| Viral Vaccines | 7 | 2025 | 316 | 0.410 |
Why?
|
| RNA-Binding Proteins | 5 | 2020 | 552 | 0.390 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 54 | 0.370 |
Why?
|
| Antigens, Viral | 13 | 2016 | 395 | 0.370 |
Why?
|
| Antibodies, Monoclonal | 3 | 2014 | 984 | 0.370 |
Why?
|
| Diarrhea | 8 | 2023 | 313 | 0.360 |
Why?
|
| Animals | 49 | 2024 | 34262 | 0.330 |
Why?
|
| Virus Cultivation | 3 | 2024 | 70 | 0.330 |
Why?
|
| Viremia | 3 | 2011 | 132 | 0.310 |
Why?
|
| Humans | 73 | 2026 | 132041 | 0.310 |
Why?
|
| Protein Transport | 6 | 2019 | 363 | 0.300 |
Why?
|
| Interferons | 2 | 2020 | 136 | 0.270 |
Why?
|
| Signal Transduction | 6 | 2023 | 4696 | 0.270 |
Why?
|
| Culture Media | 3 | 2024 | 175 | 0.260 |
Why?
|
| Protein Binding | 6 | 2025 | 1674 | 0.260 |
Why?
|
| Plasmids | 2 | 2020 | 456 | 0.250 |
Why?
|
| Polysaccharides | 3 | 2022 | 143 | 0.230 |
Why?
|
| Colon | 2 | 2021 | 361 | 0.230 |
Why?
|
| DNA Replication | 2 | 2018 | 358 | 0.230 |
Why?
|
| Immunity, Innate | 6 | 2024 | 412 | 0.230 |
Why?
|
| Blood Group Antigens | 1 | 2025 | 65 | 0.220 |
Why?
|
| Genome, Viral | 5 | 2024 | 159 | 0.220 |
Why?
|
| Feces | 12 | 2020 | 725 | 0.220 |
Why?
|
| Macrophages | 2 | 2025 | 663 | 0.210 |
Why?
|
| Immunoglobulin A | 5 | 2012 | 208 | 0.210 |
Why?
|
| Cytoplasm | 3 | 2020 | 254 | 0.210 |
Why?
|
| Phagocytosis | 1 | 2025 | 191 | 0.210 |
Why?
|
| Viral Proteins | 6 | 2014 | 339 | 0.210 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2023 | 3 | 0.210 |
Why?
|
| Rotavirus Vaccines | 3 | 2013 | 60 | 0.210 |
Why?
|
| Bacterial Toxins | 2 | 2022 | 170 | 0.210 |
Why?
|
| Bile | 2 | 2021 | 44 | 0.200 |
Why?
|
| Receptors, Virus | 2 | 2014 | 97 | 0.190 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 265 | 0.190 |
Why?
|
| Cell Membrane | 2 | 2023 | 457 | 0.190 |
Why?
|
| Mice | 19 | 2024 | 18394 | 0.180 |
Why?
|
| Trypsin | 1 | 2001 | 66 | 0.170 |
Why?
|
| Communicable Diseases | 1 | 2023 | 158 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2014 | 792 | 0.170 |
Why?
|
| Models, Biological | 3 | 2020 | 1394 | 0.170 |
Why?
|
| Reverse Genetics | 1 | 2020 | 15 | 0.170 |
Why?
|
| Cells, Cultured | 9 | 2021 | 2947 | 0.170 |
Why?
|
| Fusobacterium nucleatum | 1 | 2020 | 19 | 0.170 |
Why?
|
| Transcriptome | 3 | 2024 | 1139 | 0.160 |
Why?
|
| Adhesins, Bacterial | 1 | 2020 | 72 | 0.160 |
Why?
|
| Hepatitis B virus | 1 | 2021 | 138 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2000 | 55 | 0.160 |
Why?
|
| Calnexin | 1 | 2019 | 12 | 0.160 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 38 | 0.160 |
Why?
|
| Intracellular Membranes | 1 | 2019 | 56 | 0.160 |
Why?
|
| Ceramides | 1 | 2020 | 46 | 0.150 |
Why?
|
| Antibodies, Heterophile | 1 | 1999 | 8 | 0.150 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2000 | 78 | 0.150 |
Why?
|
| Vaccines, Synthetic | 5 | 1998 | 319 | 0.150 |
Why?
|
| Virus Diseases | 2 | 2021 | 285 | 0.150 |
Why?
|
| Organ Culture Techniques | 2 | 2018 | 144 | 0.150 |
Why?
|
| Biliary Atresia | 2 | 2013 | 220 | 0.150 |
Why?
|
| Infant | 7 | 2024 | 13343 | 0.150 |
Why?
|
| Molecular Sequence Data | 11 | 2014 | 3534 | 0.150 |
Why?
|
| Virus Physiological Phenomena | 1 | 2018 | 12 | 0.140 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 64 | 0.140 |
Why?
|
| Inclusion Bodies | 2 | 2018 | 39 | 0.140 |
Why?
|
| Amino Acid Sequence | 8 | 2014 | 2422 | 0.140 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 2357 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1950 | 0.130 |
Why?
|
| Clostridium Infections | 1 | 2020 | 248 | 0.130 |
Why?
|
| Baculoviridae | 5 | 2004 | 41 | 0.130 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2010 | 126 | 0.130 |
Why?
|
| Virus Shedding | 3 | 2014 | 75 | 0.120 |
Why?
|
| Phosphorylation | 5 | 2020 | 1571 | 0.120 |
Why?
|
| Enterotoxins | 3 | 2008 | 77 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2014 | 350 | 0.120 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2014 | 6 | 0.110 |
Why?
|
| Flagellin | 1 | 2014 | 20 | 0.110 |
Why?
|
| Cricetinae | 5 | 2020 | 366 | 0.110 |
Why?
|
| Transplant Recipients | 1 | 2016 | 232 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2014 | 78 | 0.110 |
Why?
|
| Peptide Library | 1 | 2014 | 57 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 313 | 0.100 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 43 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2014 | 162 | 0.100 |
Why?
|
| Models, Molecular | 4 | 2025 | 1062 | 0.100 |
Why?
|
| Immunization, Passive | 2 | 2013 | 123 | 0.100 |
Why?
|
| Interleukins | 1 | 2014 | 121 | 0.100 |
Why?
|
| Jejunum | 2 | 2024 | 124 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2014 | 69 | 0.100 |
Why?
|
| Genotype | 3 | 2014 | 2655 | 0.100 |
Why?
|
| Child, Preschool | 4 | 2023 | 15089 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 366 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 372 | 0.100 |
Why?
|
| Organ Specificity | 3 | 2018 | 400 | 0.100 |
Why?
|
| Crystallography, X-Ray | 3 | 2022 | 365 | 0.100 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2012 | 12 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2012 | 497 | 0.100 |
Why?
|
| Autophagy-Related Proteins | 1 | 2012 | 37 | 0.100 |
Why?
|
| Travel | 1 | 2014 | 130 | 0.100 |
Why?
|
| Secretory Pathway | 1 | 2012 | 10 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 63 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 4 | 2010 | 390 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 836 | 0.090 |
Why?
|
| Biopsy | 1 | 2016 | 1254 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2012 | 36 | 0.090 |
Why?
|
| Serpins | 2 | 2004 | 34 | 0.090 |
Why?
|
| N-Acetylneuraminic Acid | 3 | 2013 | 23 | 0.090 |
Why?
|
| Host Specificity | 1 | 2012 | 17 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2014 | 168 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 62 | 0.090 |
Why?
|
| Animals, Newborn | 4 | 2013 | 1020 | 0.090 |
Why?
|
| Viral Structural Proteins | 2 | 2010 | 39 | 0.090 |
Why?
|
| Cryoelectron Microscopy | 2 | 2025 | 239 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 589 | 0.090 |
Why?
|
| Crassostrea | 1 | 2011 | 4 | 0.090 |
Why?
|
| Osteopontin | 1 | 2011 | 52 | 0.090 |
Why?
|
| Nanostructures | 1 | 2011 | 64 | 0.090 |
Why?
|
| Cell Polarity | 2 | 2022 | 121 | 0.090 |
Why?
|
| Cholestasis | 1 | 2013 | 165 | 0.090 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2011 | 106 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 181 | 0.080 |
Why?
|
| RNA, Double-Stranded | 2 | 2010 | 58 | 0.080 |
Why?
|
| Child | 5 | 2023 | 26361 | 0.080 |
Why?
|
| Nuclear Export Signals | 1 | 2010 | 1 | 0.080 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 181 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2012 | 248 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 20 | 0.080 |
Why?
|
| Enterocytes | 2 | 2024 | 68 | 0.080 |
Why?
|
| Microscopy, Electron | 4 | 2010 | 316 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 61 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2010 | 450 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2010 | 116 | 0.080 |
Why?
|
| Chemokines | 2 | 2026 | 127 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2004 | 511 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 676 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2014 | 4691 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 831 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 986 | 0.070 |
Why?
|
| Integrin alpha1beta1 | 1 | 2008 | 3 | 0.070 |
Why?
|
| Integrin alpha2beta1 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Recombinant Proteins | 6 | 2012 | 1320 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2010 | 241 | 0.070 |
Why?
|
| Interleukin-8 | 3 | 2010 | 207 | 0.070 |
Why?
|
| Rabbits | 5 | 2003 | 579 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2012 | 3864 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2010 | 437 | 0.070 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2007 | 2 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 303 | 0.060 |
Why?
|
| Liver | 3 | 2021 | 1805 | 0.060 |
Why?
|
| Genetic Vectors | 4 | 2005 | 906 | 0.060 |
Why?
|
| Mutation | 5 | 2025 | 6197 | 0.060 |
Why?
|
| Escherichia coli | 3 | 2021 | 983 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2006 | 38 | 0.060 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 67 | 0.060 |
Why?
|
| Immunity, Mucosal | 3 | 2010 | 90 | 0.060 |
Why?
|
| Intussusception | 1 | 2006 | 55 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1615 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 420 | 0.060 |
Why?
|
| CHO Cells | 3 | 2013 | 149 | 0.060 |
Why?
|
| HT29 Cells | 2 | 2020 | 44 | 0.060 |
Why?
|
| Golgi Apparatus | 3 | 2012 | 91 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 719 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 1147 | 0.060 |
Why?
|
| Female | 15 | 2024 | 71380 | 0.060 |
Why?
|
| Endocytosis | 1 | 2025 | 127 | 0.060 |
Why?
|
| Vaccines | 1 | 2010 | 383 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2025 | 239 | 0.050 |
Why?
|
| Actins | 1 | 2007 | 317 | 0.050 |
Why?
|
| DNA Primers | 3 | 2008 | 609 | 0.050 |
Why?
|
| Cattle | 5 | 2013 | 503 | 0.050 |
Why?
|
| Neutralization Tests | 6 | 2005 | 226 | 0.050 |
Why?
|
| Rats | 3 | 2006 | 3458 | 0.050 |
Why?
|
| Receptors, Purinergic | 1 | 2023 | 14 | 0.050 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2023 | 17 | 0.050 |
Why?
|
| Spodoptera | 2 | 2003 | 28 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2025 | 804 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2023 | 87 | 0.050 |
Why?
|
| Base Sequence | 5 | 2008 | 2783 | 0.050 |
Why?
|
| Immunoglobulin G | 4 | 2012 | 796 | 0.050 |
Why?
|
| Nucleotides | 1 | 2023 | 90 | 0.050 |
Why?
|
| Cytokines | 2 | 2025 | 1356 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2004 | 217 | 0.050 |
Why?
|
| Clathrin | 1 | 2023 | 23 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2025 | 810 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2003 | 164 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2012 | 622 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 1270 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 2014 | 436 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2018 | 734 | 0.050 |
Why?
|
| Pyridines | 1 | 2024 | 259 | 0.050 |
Why?
|
| Freund's Adjuvant | 2 | 1999 | 21 | 0.050 |
Why?
|
| Escherichia coli Infections | 2 | 2021 | 196 | 0.050 |
Why?
|
| Galectins | 1 | 2022 | 23 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 633 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 2 | 2014 | 54 | 0.050 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.040 |
Why?
|
| Integrins | 1 | 2002 | 90 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2022 | 114 | 0.040 |
Why?
|
| Endosomes | 1 | 2022 | 72 | 0.040 |
Why?
|
| Calcitriol | 1 | 2021 | 62 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2021 | 79 | 0.040 |
Why?
|
| Laminin | 1 | 2021 | 68 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2024 | 358 | 0.040 |
Why?
|
| Adult | 6 | 2024 | 31747 | 0.040 |
Why?
|
| Colostrum | 2 | 1998 | 58 | 0.040 |
Why?
|
| Flagella | 1 | 2020 | 27 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2020 | 39 | 0.040 |
Why?
|
| Immunization | 2 | 1999 | 269 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 2001 | 69 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2001 | 52 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 280 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2000 | 61 | 0.040 |
Why?
|
| Bioreactors | 1 | 2020 | 44 | 0.040 |
Why?
|
| Immunoassay | 2 | 2014 | 129 | 0.040 |
Why?
|
| Transfection | 4 | 2007 | 960 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 230 | 0.040 |
Why?
|
| Administration, Intranasal | 3 | 2010 | 130 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2020 | 104 | 0.040 |
Why?
|
| Glycochenodeoxycholic Acid | 1 | 2020 | 7 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2024 | 8613 | 0.040 |
Why?
|
| Japan | 1 | 2000 | 177 | 0.040 |
Why?
|
| Hemagglutination Tests | 2 | 2013 | 10 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 46 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 289 | 0.040 |
Why?
|
| Respiratory System | 1 | 2000 | 96 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2003 | 2585 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 113 | 0.040 |
Why?
|
| Biofilms | 1 | 2020 | 98 | 0.040 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2020 | 43 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2016 | 1240 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2001 | 86 | 0.040 |
Why?
|
| Kidney | 2 | 2010 | 1303 | 0.040 |
Why?
|
| Male | 9 | 2024 | 65425 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2001 | 239 | 0.040 |
Why?
|
| Pancreas | 1 | 2000 | 228 | 0.040 |
Why?
|
| Casein Kinase Ialpha | 1 | 2018 | 4 | 0.040 |
Why?
|
| Caliciviridae | 1 | 1999 | 12 | 0.040 |
Why?
|
| Stomach | 1 | 2021 | 274 | 0.040 |
Why?
|
| Plasma Volume | 1 | 1998 | 12 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 2018 | 33 | 0.040 |
Why?
|
| Platelet Activating Factor | 1 | 1998 | 23 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1998 | 43 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 943 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 291 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1998 | 26 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 136 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2014 | 201 | 0.030 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 36 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2014 | 1019 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2000 | 310 | 0.030 |
Why?
|
| Cause of Death | 1 | 2000 | 511 | 0.030 |
Why?
|
| Endotoxemia | 1 | 1998 | 54 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 231 | 0.030 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1998 | 35 | 0.030 |
Why?
|
| Species Specificity | 2 | 2014 | 496 | 0.030 |
Why?
|
| Spleen | 1 | 1998 | 257 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1236 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 355 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 317 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 299 | 0.030 |
Why?
|
| Moths | 2 | 1994 | 17 | 0.030 |
Why?
|
| Acute Disease | 1 | 2000 | 1153 | 0.030 |
Why?
|
| Vaccines, DNA | 1 | 1997 | 45 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 294 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2000 | 529 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2016 | 84 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 1220 | 0.030 |
Why?
|
| Gene Expression | 4 | 2004 | 1508 | 0.030 |
Why?
|
| Haplorhini | 2 | 2010 | 106 | 0.030 |
Why?
|
| Microscopy | 1 | 2016 | 121 | 0.030 |
Why?
|
| Genes, Viral | 3 | 1999 | 155 | 0.030 |
Why?
|
| Proteins | 1 | 2001 | 1014 | 0.030 |
Why?
|
| Virosomes | 1 | 2014 | 3 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2014 | 36 | 0.030 |
Why?
|
| Hemagglutinins, Viral | 1 | 1994 | 17 | 0.030 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 414 | 0.030 |
Why?
|
| Injections, Intramuscular | 3 | 2003 | 187 | 0.030 |
Why?
|
| Helicobacter pylori | 1 | 2004 | 1359 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 2014 | 44 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 131 | 0.030 |
Why?
|
| COS Cells | 1 | 2014 | 249 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 1998 | 454 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 4733 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 366 | 0.030 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 152 | 0.030 |
Why?
|
| Ion Transport | 1 | 2013 | 48 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 256 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2014 | 167 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2014 | 125 | 0.020 |
Why?
|
| Mexico | 1 | 2014 | 198 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 194 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2014 | 157 | 0.020 |
Why?
|
| Virus Attachment | 1 | 2013 | 32 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 227 | 0.020 |
Why?
|
| Cricetulus | 1 | 2013 | 88 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 817 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2012 | 46 | 0.020 |
Why?
|
| Hardness | 1 | 2011 | 4 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2011 | 11 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2014 | 315 | 0.020 |
Why?
|
| United States | 2 | 2014 | 11846 | 0.020 |
Why?
|
| Rodent Diseases | 1 | 2011 | 15 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2011 | 96 | 0.020 |
Why?
|
| Cell Movement | 2 | 2008 | 882 | 0.020 |
Why?
|
| Surface Properties | 1 | 2011 | 82 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 80 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2012 | 191 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 570 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2011 | 32 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 590 | 0.020 |
Why?
|
| Cholera Toxin | 2 | 2003 | 43 | 0.020 |
Why?
|
| Digestive System | 1 | 2011 | 61 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2011 | 51 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 432 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 178 | 0.020 |
Why?
|
| India | 1 | 2011 | 245 | 0.020 |
Why?
|
| Virus Inactivation | 1 | 2010 | 10 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 16 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 47 | 0.020 |
Why?
|
| Hemocyanins | 1 | 2010 | 23 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2005 | 54 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 148 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2010 | 113 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2010 | 47 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 137 | 0.020 |
Why?
|
| Viral Core Proteins | 1 | 1989 | 17 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 192 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 487 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 338 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 1746 | 0.020 |
Why?
|
| Antibodies | 1 | 2010 | 323 | 0.020 |
Why?
|
| Estrenes | 1 | 2008 | 16 | 0.020 |
Why?
|
| Pyrrolidinones | 1 | 2008 | 22 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1525 | 0.020 |
Why?
|
| Androstadienes | 1 | 2008 | 50 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2003 | 710 | 0.020 |
Why?
|
| Time Factors | 3 | 2008 | 6283 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 771 | 0.020 |
Why?
|
| DEAD Box Protein 58 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2007 | 25 | 0.020 |
Why?
|
| Insect Viruses | 1 | 1987 | 5 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2008 | 228 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 310 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1484 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 2007 | 31 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1989 | 432 | 0.020 |
Why?
|
| Gastrointestinal Transit | 1 | 2006 | 28 | 0.020 |
Why?
|
| Fetus | 1 | 2010 | 585 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 126 | 0.020 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2006 | 8 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 787 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2007 | 162 | 0.020 |
Why?
|
| Reassortant Viruses | 1 | 2006 | 28 | 0.010 |
Why?
|
| Genes | 1 | 1986 | 308 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 1148 | 0.010 |
Why?
|
| Mesocricetus | 1 | 2005 | 69 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2005 | 50 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 236 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2005 | 112 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2005 | 78 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 382 | 0.010 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 10 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 2004 | 17 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 7588 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 53 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2004 | 63 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 542 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2004 | 48 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 905 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 644 | 0.010 |
Why?
|
| Insecta | 1 | 2004 | 50 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 291 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1999 | 283 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 273 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 144 | 0.010 |
Why?
|
| Vaccines, Attenuated | 1 | 2003 | 174 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1705 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1625 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 492 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 57 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 612 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 2002 | 6 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2002 | 18 | 0.010 |
Why?
|
| Sialic Acids | 1 | 2002 | 17 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 2002 | 26 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2002 | 54 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2001 | 27 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 112 | 0.010 |
Why?
|
| Neuraminidase | 1 | 2002 | 40 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 5124 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2004 | 414 | 0.010 |
Why?
|
| Microvilli | 1 | 2001 | 64 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 28946 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 623 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 1490 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2000 | 232 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 418 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3703 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 10128 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1998 | 16 | 0.010 |
Why?
|
| Saponins | 1 | 1998 | 21 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 2148 | 0.010 |
Why?
|
| Endotoxins | 1 | 1998 | 50 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1998 | 16 | 0.010 |
Why?
|
| Chemokine CXCL1 | 1 | 1998 | 15 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 36 | 0.010 |
Why?
|
| Titrimetry | 1 | 1998 | 6 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 110 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1998 | 53 | 0.010 |
Why?
|
| Growth Substances | 1 | 1998 | 102 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 471 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1999 | 452 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 1188 | 0.010 |
Why?
|
| Milk | 1 | 1996 | 109 | 0.010 |
Why?
|
| Homeostasis | 1 | 1998 | 715 | 0.010 |
Why?
|
| Apoptosis | 1 | 2001 | 1863 | 0.010 |
Why?
|
| Vaccination | 1 | 1998 | 1041 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1998 | 1347 | 0.010 |
Why?
|
| Solubility | 1 | 1991 | 117 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1991 | 199 | 0.000 |
Why?
|
| Adolescent | 1 | 2008 | 21018 | 0.000 |
Why?
|
| Immune Sera | 1 | 1989 | 55 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1989 | 155 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1986 | 62 | 0.000 |
Why?
|
| Protein Sorting Signals | 1 | 1986 | 41 | 0.000 |
Why?
|
| Codon | 1 | 1986 | 95 | 0.000 |
Why?
|
| DNA | 1 | 1991 | 1440 | 0.000 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1986 | 360 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1986 | 579 | 0.000 |
Why?
|